Novel therapeutic targets in depression: Minocycline as a candidate treatment
详细信息 查看全文
- 作者：Joanna K. Soczynska ; Rodrigo B. Mansur ; Elisa Brietzke ; Walter Swardfager ; Sidney H. Kennedy ; Hanna O. Woldeyohannes ; Alissa M. Powell ; Marena S. Manierka ; Roger S. McIntyre
- 关键词：Bipolar disorder ; Major depression ; Inflammation ; Neuroplasticity ; Glutamate ; Oxidative stress ; Minocycline
- 刊名：Behavioural Brain Research
- 出版年：2012
- 出版时间：1 December, 2012
- 年：2012
- 卷：235
- 期：2
- 页码：302-317
- 全文大小：930 K
文摘
Mood disorders are marked by high rates of non-recovery, recurrence, and chronicity, which are insufficiently addressed by current therapies. Several patho-etiological models have been proposed that are not mutually exclusive and include but are not limited to the monoamine, inflammatory, neurotrophic, gliotrophic, excitatory, and oxidative stress systems. A derivative of these observations is that treatment(s) which target one or more of these mechanistic steps may be capable of mitigating, or preventing, disparate psychopathological features. Minocycline is an agent with pleiotropic properties that targets multiple proteins and cellular processes implicated in the patho-etiology of mood disorders. Moreover, preclinical and preliminary clinical evidence suggests that minocycline possesses antidepressant properties. Herein, we provide the rationale for conducting a randomized, controlled trial to test the antidepressant properties of minocycline.